Dynavax Technologies Corp
2929 Seventh Street Suite 10094710 Berkeley , California
Registration country:United States
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, engages in the discovery and development of products to prevent and treat infectious diseases, asthma, and inflammatory and autoimmune diseases. The company’s pipeline of product candidates includes HEPLISAV; Universal Flu vaccine; clinical-stage programs for hepatitis C and hepatitis B therapies; and preclinical programs partnered with AstraZeneca and GlaxoSmithKline (GSK).